Skip to main content
Log in

Expression and significance of coxsackie and adenovirus receptor in renal-cell carcinoma

  • Original Article
  • Published:
Chinese Journal of Clinical Oncology

Abstract

Objective

To investigate the expression of Coxsackie and Adenovirus receptor (CAR) in renal-cell carcinoma and the relationship of the CAR to the biological behavior of the carcinomas.

Methods

The immunohistochemical SP method was used to detect the expression of Coxsackie and Adenovirus receptor in 48 cases of renalcell carcinoma and in 12 cases of normal renal tissue 2 cm away from the tumor tissue.

Results

The positive rates of CAR were 100% in 12 cases of para-tu-mor normal renal tissue and 35.4% in 48 cases of renal-cell carcinoma respectively. The difference of CAR expression between them was significant (P<0.05). The grades of the tumor were as follows: 22 in Grade I, 17 in Grade II and 9 in Grade III with the CAR positive rate being 54.5%, 23.5% and 11.1%, respectively. There was a negative correlation between CAR expression and tumor grading (P<0.05). In addition, the number of the cases in stages I to IV were 19, 13, 11 and 5 respectively, with the respective positive rates being 57.9%, 30.8%, 18.2% and 0.0%, i.e. there also was a negative relationship between CAR expression and the stage (P<0.05).

Conclusion

CAR expression is down-regulated in renal-cell carcinoma compared with normal tissue. The level of CAR may be a sensitive predictor of differentiation, invasion and metastasis. Loss of CAR expression correlates with the invasive phenotype in our analysis of renal -cell carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bergelson JM, Cunningham JA, Drouguett G, et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science. 1997; 275: 1320–1323.

    Article  PubMed  CAS  Google Scholar 

  2. Li Y, Pong RC, Hall MC, et al. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res. 1999; 59: 325–330.

    PubMed  CAS  Google Scholar 

  3. Cohen CJ, Shieh JT, Pickles RJ, et al. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci USA. 2001; 98: 15191–15196.

    Article  PubMed  CAS  Google Scholar 

  4. Kim M, Sumerel LA, Belousova N, et al. The coxsackievirus and adenovirus receptor acts as a tumor suppressor in malignant glioma cells. Br J Cancer. 2003; 88: 1411–1420.

    Article  PubMed  CAS  Google Scholar 

  5. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982; 6: 655–663.

    Article  PubMed  CAS  Google Scholar 

  6. Katherine AR, Sudilovsky D, Le JL, et al. Expression of the Coxsackie Adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy. Cancer Res. 2002; 62: 3812–3818.

    Google Scholar 

  7. Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA. 1997; 94: 3352–3356.

    Article  PubMed  CAS  Google Scholar 

  8. Okegawa T, Pong RC, Li Y, et al. The mechanism of growth inhibitory effect of coxsackie and adenovirus receptor(CAR) on human bladder cancer: a functional analysis of CAR protein structure. Cancer Res. 2001; 61: 6592–6600.

    PubMed  CAS  Google Scholar 

  9. Tomko RP, Johansson CB, Totrov M, et al. Expression of the adenovirus receptor and its interaction with the fiber knob. Exp Cell Res. 2000; 255: 47–55.

    Article  PubMed  CAS  Google Scholar 

  10. Fechner H, Wang X, Wang H, et al. Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells. Gene Ther. 2000; 7: 1954–1968.

    Article  PubMed  CAS  Google Scholar 

  11. Fuxe J, Liu L, Malin S, et al. Expression of the coxsackie and adenovirus receptor in human astrocytic tumors and xenografts. Int J Cancer. 2003; 103: 723–729.

    Article  PubMed  CAS  Google Scholar 

  12. Okegawa T, Li Y, Pong RC, et al. The impact of coxsackie and adenovirus receptor on human prostate cancer gene therapy. Cancer Res. 2000; 60: 5031–5036.

    PubMed  CAS  Google Scholar 

  13. Loskog A, Hedlund T, Wester K, et al. human urinary bladder carcinomas express adenovirus attachment and internalization receptors. Gene Ther. 2002; 9: 547–553.

    Article  PubMed  CAS  Google Scholar 

  14. Sachs MD, Rauen KA, Ramamurthy M, et al. Integrin alpha (v) and coxsackie adenovirus receptor expression in clinical bladder cancer. Urology. 2002; 60: 531–536.

    Article  PubMed  Google Scholar 

  15. Haviv YS, Blackwell JL, Kanerva A, et al. Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors. Cancer Res. 2002; 62: 4273–4281.

    PubMed  CAS  Google Scholar 

  16. Bruning A, Runnebaum IB. The coxsackie adenovirus receptor inhibits cancer cell migration. Exp Cell Res. 2004; 298: 624–631.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dalin He.

Additional information

This work was supported by the National Backbone Teachers Fund of Ministry of Education (No.[00]143).

About this article

Cite this article

Zhang, L., He, D., Li, X. et al. Expression and significance of coxsackie and adenovirus receptor in renal-cell carcinoma. Chin. J. Clin. Oncol. 2, 787–790 (2005). https://doi.org/10.1007/BF02772877

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02772877

Keywords

Navigation